Hong Kong stock loans.
Institutional financing structured against shares listed on the Hong Kong Stock Exchange. For shareholders who need capital today, without selling tomorrow.
A precise instrument with a simple premise.
A Hong Kong stock loan is a financing transaction in which a shareholder of an HKEX-listed company pledges shares as collateral to access cash, while retaining the economic upside and the right to recover the full position on repayment.
It is, in essence, a way to extract liquidity from a position without extracting the holder from the position. The shareholder retains beneficial ownership, retains the right to dividends (subject to structuring), and retains the option to participate in long-term value creation. What changes is access to capital — substantial, deployable, and delivered in days rather than quarters.
Stock loans are particularly relevant in Hong Kong because of the depth, liquidity, and global reach of the HKEX, and because the city’s controlling-shareholder structures, family-office concentrations, and cross-border investment flows generate a continuous need for discreet, large-scale share-backed financing.
The shares stay yours. The capital is freed.
A founder, controlling shareholder, or steward of multigenerational wealth should not be forced to choose between liquidity and ownership. A well-structured stock loan refuses this false choice.
Ownership preserved
Beneficial ownership and the underlying economic exposure remain with the shareholder. Shares are pledged, not sold.
Liquidity delivered
Substantial cash is deployed against the collateral position, typically within a small number of business days from documentation.
Optionality intact
Long-term participation in value creation is preserved. The position can be recovered in full on repayment.
Discretion enforced
Transactions are documented and executed without market signalling. Disclosure obligations, where they apply, are managed deliberately.
Selective by design.
Hong Kong stock loans are not retail products. They are institutional instruments designed for a defined set of counterparties, structured around specific positions, and executed in considered time.
- iControlling shareholders of HKEX-listed companies seeking liquidity without disturbing the control position.
- iiCompany founders with concentrated personal holdings who require capital for diversification, philanthropy, or other strategic deployment.
- iiiPublic corporates holding treasury or strategic positions in listed equity who require working capital secured against those positions.
- vFamily offices managing concentrated single-stock exposure as part of broader generational wealth structures.
- viStrategic investors with substantial holdings used as collateral for new investments or commitments.
Transactions are typically structured for positions valued from HKD 10 million upward, with no defined upper bound. We have arranged transactions well into nine figures.
Bespoke structure. Institutional documentation.
No two transactions are identical. Each is structured against the specific characteristics of the underlying position, the holder’s objectives, and the prevailing market and regulatory context.
Loan-to-value (LTV)
LTV is the single most consequential structural variable. Indicative ratios are issued only after a review of the specific ticker, with material weight given to:
- ·Free float and average daily trading volume
- ·Market capitalisation and price stability
- ·Sector, business model, and earnings profile
- ·Shareholder concentration and any insider status
- ·Recent corporate actions and regulatory standing
Tenor & recourse
Tenor is typically structured between 12 and 36 months, with bespoke options outside that range where strategically appropriate. Recourse is determined transaction by transaction:
- ·Non-recourse arrangements where the underlying liquidity and structure support them
- ·Limited-recourse structures with negotiated coverage
- ·Full-recourse where the borrower’s broader balance sheet is part of the credit profile
Currency & settlement
Transactions settle in HKD, USD, or selected major currencies. Currency choice is determined by counterparty preference, banking jurisdiction, and use-of-proceeds requirements. Cross-border settlement is routine; correspondent banking relationships span Hong Kong, Singapore, Greater China, and major Western financial centres.
Pricing
Pricing is calibrated to the underlying credit and structural profile of the transaction. There is no published rate sheet; competitive institutional pricing is delivered as part of indicative terms following an initial position review.
Bankruptcy-remote custody. Beneficial ownership preserved.
Custody is one of the technical foundations of a well-structured stock loan. The pledged position must be held in a manner that protects all parties, supports the security interest of the lender, and preserves the underlying economic position of the borrower.
Pledged shares are held by qualified custodians under bankruptcy-remote arrangements. The structure is designed so that the borrower’s beneficial ownership and economic exposure are preserved throughout the life of the facility, while the lender’s security interest is fully perfected.
Dividend treatment, voting rights, and corporate-action mechanics are addressed deliberately in the documentation. Each is a matter of structuring, not boilerplate.
The regulatory perimeter matters.
Hong Kong stock loans operate within a regulatory framework defined principally by the Securities and Futures Ordinance, the HKEX Listing Rules, and the SFC Codes on Takeovers and Mergers. Whether and how a particular transaction triggers disclosure obligations depends on the shareholder’s status, the size of the position, the structure used, and the timing of execution.
Where the shareholder is a director, substantial shareholder, or other person subject to the Disclosure of Interests regime under Part XV of the SFO, the structure must be calibrated accordingly. Where the transaction approaches or implicates the Takeovers Code thresholds, the structuring becomes more involved. Where the underlying issuer is a Chapter 18A biotech, a GEM listing, or a recently-listed Main Board issuer, additional sensitivity applies.
Every transaction is assessed for regulatory implications at the outset, with experienced Hong Kong counsel of the borrower’s choosing engaged in parallel with structuring. We do not provide legal advice; we structure transactions that legal advice can endorse.